Assessing the Prevalence of Hemophilia Among Visitors to the Central Bank of Kabul, Afghanistan, in 2023

Introduction: Introduction: Haemophilia is a rare genetic disorder characterized by excessive bleeding and debilitating joint pain resulting from deficiencies in coagulation factors VIII and IX. This cross-sectional study investigates the prevalence of haemophilia and associated factors in Afghanistan in 2023. Materials and Methods: A cross-sectional study was conducted in 2023 involving a set of patients diagnosed with haemophilia in Kabul central blood bank. Demographic information was collected through structured interviews, while coagulation factor levels were determined using a one-step assay. Results: A total of 201 patients had haemophilia A, 21 had haemophilia B, which were mainly classified as severe. Of note, only one patient was diagnosed with HIV, HBV and HCV, emphasizing the need for ongoing surveillance. Conlusion: The findings indicate a concerning prevalence of Haemophilia in Afghanistan, underscoring the urgent need for improved screening, diagnosis, and treatment options. This study emphasizes the necessity for enhanced diagnostic resources and targeted interventions to better support affected individuals and improve overall health outcomes in the country. Additionally, the results will provide a foundation for future research and advocacy efforts in the region.